He is the president of the American Society of Endocrine Physician Assistants. Sadler has completed a disclosure statement and reports that he is a consultant for sanofi-aventis and Boehringer Ingelheim/Lilly. He serves on speaker bureaus for Bristol-Myers Squibb, Novo Nordisk and Takeda. Medical writing assistance was provided by Cherie Koch, PhD, of MedErgy and was funded by sanofi-aventis. The author received no compensation and retained full editorial control over the content of the manuscript.